K Number
K063677
Device Name
FUSION QUATTRO EXTRACTION BALLOON XL
Date Cleared
2007-01-05

(25 days)

Product Code
Regulation Number
876.5010
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
Used for endoscopic removal of stones in the biliary system and for contrast injection.
Device Description
The subject extraction balloon represents modifications made to existing extraction balloons currently marketed by Cook Endoscopy. The Fusion Quattro Extraction Balloon XL is supplied sterile and intended for single use only.
More Information

Not Found

No
The summary describes a mechanical device (extraction balloon) and does not mention any software, image processing, or AI/ML terms.

No
The device is used for removal of stones, which is a therapeutic intervention, but the document does not explicitly state that the device itself is a "therapeutic device" based on a commonly accepted definition. Rather, it is an accessory used during a therapeutic procedure.

No
The device is described as an "extraction balloon" used for "endoscopic removal of stones" and "contrast injection," indicating a therapeutic rather than diagnostic function.

No

The device description explicitly states it is an "extraction balloon," which is a physical, hardware component used in endoscopic procedures.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use is for "endoscopic removal of stones in the biliary system and for contrast injection." This describes a procedure performed within the body (in vivo) to treat a condition, not a test performed outside the body (in vitro) on biological samples to diagnose a condition.
  • Device Description: The description of an "extraction balloon" used endoscopically further supports its use within the body.
  • Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, urine, tissue, etc.), detecting analytes, or providing diagnostic information based on laboratory testing.

Therefore, this device falls under the category of a surgical or therapeutic device used in a medical procedure, not an in vitro diagnostic device.

N/A

Intended Use / Indications for Use

Used for endoscopic removal of stones in the biliary system and for contrast injection.

Product codes

78 GCA, GCA

Device Description

The subject extraction balloon represents modifications made to existing extraction balloons currently marketed by Cook Endoscopy. The Fusion Quattro Extraction Balloon XL is supplied sterile and intended for single use only.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

biliary system

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

We believe risks associated with the modifications to the subject device to be adequately addressed through our Design Control Process. We believe the proposed device to be substantially equivalent to the named predicate in terms of Intended Use, performance characteristics tested and biocompatibility.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K040129

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 876.5010 Biliary catheter and accessories.

(a)
Identification. A biliary catheter and accessories is a tubular flexible device used for temporary or prolonged drainage of the biliary tract, for splinting of the bile duct during healing, or for preventing stricture of the bile duct. This generic type of device may include a bile collecting bag that is attached to the biliary catheter by a connector and fastened to the patient with a strap.(b)
Classification. Class II (special controls). The device, when it is a bile collecting bag or a surgical biliary catheter that does not include a balloon component, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.

0

Image /page/0/Picture/0 description: The image shows the text "K063677" on the top line. The second line of text says "PAGE 1 of 1". The text is black and the background is white.

Image /page/0/Picture/1 description: The image shows the word "COOK" in all capital letters. There is a registered trademark symbol after the K. The font is a serif font and the letters are black.

Cook Endoscopy

4900 Bethania Station Road Winston-Salem, NC 27105 Phone: 336 744-0157 Customer Service: 800 457-4500 Fax: 336 744-1147 • 800 743-1147 www.cookendoscopy.com

JAN - 6 2007

510(k) Summary

Name:Cook Endoscopy
Address:4900 Bethania Station Road Winston-Salem, NC 27105
Phone:336-744-0157
Fax:336-201-5994
Contact Person:Scottie Fariole, Global Regulatory Affairs Specialist
Date:December 8, 2006
Trade Name:Fusion Quattro Extraction Balloon XL
Common Name:Extraction Balloon
Classification Name:Catheter, Biliary, Surgical (21 CFR 876.5010, Product Code 78 GCA)
Legally Marketed Devices:Tri-Ex Extraction Balloon with Multiple Sizing (K040129)
Description of the Device:The subject extraction balloon represents modifications made to existing extraction balloons currently marketed by Cook Endoscopy. The Fusion Quattro Extraction Balloon XL is supplied sterile and intended for single use only.
Intended Use:Used for endoscopic removal of stones in the biliary system and for contrast injection.
Comparison of Characteristics:We believe the proposed device to be substantially equivalent to currently marketed predicate device as cleared by K040129.
Performance Data:We believe risks associated with the modifications to the subject device to be adequately addressed through our Design Control Process. We believe the proposed device to be substantially equivalent to the named predicate in terms of Intended Use, performance characteristics tested and biocompatibility.

1

Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is circular and contains the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of an eagle or bird-like figure, composed of three curved lines that suggest feathers or wings.

Food and Drug Administration 9200 Corporate Blvd. Rockville MD 20850

JAN 0 5 2007

Ms. Scottie Fariole Global Regulatory Affairs Specialist Cook Endoscopy 4900 Bethania Station Road WINSTON-SALEM NC 27105

Re: K063677

Trade/Device Name: Modified Fusion Quattro Extraction Balloon XL Regulation Number: 21 CFR §876.5010 Regulation Name: Biliary catheter and Accessories Regulatory Class: II Product Code: GCA Dated: December 8, 2006 Received: December 11, 2006

Dear Ms. Fariole:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Image /page/1/Picture/10 description: The image shows the FDA Centennial logo, which includes the years 1906-2006. Below the logo is the text "Protecting and Promoting Public Health". The logo is circular in shape and contains the letters FDA in a stylized font. The text is written in a decorative font.

2

Page 2 -

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter:

21 CFR 876.xxx(Gastroenterology/Renal/Urology)240-276-0115
21 CFR 884.xxx(Obstetrics/Gynecology)240-276-0115
21 CFR 894.xxx(Radiology)240-276-0120
Other240-276-0100

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150

or at its Internet address http://www.fda.gov/cdrl/industry/support/index.html.

Sincerely yours,

Nancy C. Hogdon

Nancy C. Brogdon Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

3

Indications for Use

510(k) Number (if known): _KO63677

Device Name: Eusion Quattro Extraction Balloon XL

Indications for Use:

Used for endoscopic removal of stones in the biliary system and for contrast injection.

Prescription Use (Part 21 CFR 801 Subpart D)

AND/OR

Over-The-Counter Use (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

David A. Segerson

(Division Sign-Off) Division of Reproductive, Abdominal, and Radiological Devices 510(k) Number ________________________________________________________________________________________________________________________________________________________________

Page 1 of 1